SPECGX LLC FDA Approval ANDA 087804

ANDA 087804

SPECGX LLC

FDA Drug Application

Application #087804

Application Sponsors

ANDA 087804SPECGX LLC

Marketing Status

Prescription001

Application Products

001TABLET;ORAL325MG;50MG;40MG0BUTALBITAL, ACETAMINOPHEN AND CAFFEINEACETAMINOPHEN; BUTALBITAL; CAFFEINE

FDA Submissions

ORIG1AP1985-01-24
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1992-09-03
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1996-06-20
LABELING; LabelingSUPPL9AP1988-05-18
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1992-09-03
LABELING; LabelingSUPPL11AP1988-08-24
LABELING; LabelingSUPPL12AP1989-11-21
LABELING; LabelingSUPPL16AP1992-07-16
LABELING; LabelingSUPPL18AP1993-05-27
LABELING; LabelingSUPPL19AP1994-03-16
LABELING; LabelingSUPPL20AP1994-06-13
MANUF (CMC); Manufacturing (CMC)SUPPL21AP1994-09-29
MANUF (CMC); Manufacturing (CMC)SUPPL24AP1998-11-23
LABELING; LabelingSUPPL25AP1998-11-23
LABELING; LabelingSUPPL26AP1998-08-19
MANUF (CMC); Manufacturing (CMC)SUPPL27AP2000-07-26
MANUF (CMC); Manufacturing (CMC)SUPPL28AP2002-08-26
MANUF (CMC); Manufacturing (CMC)SUPPL29AP2002-08-26
LABELING; LabelingSUPPL30AP2002-10-21
LABELING; LabelingSUPPL34AP2006-10-10
LABELING; LabelingSUPPL38AP2012-01-20
LABELING; LabelingSUPPL39AP2013-10-18STANDARD

Submissions Property Types

SUPPL6Null0
SUPPL7Null0
SUPPL10Null0
SUPPL21Null0
SUPPL24Null0
SUPPL27Null0
SUPPL28Null0
SUPPL29Null0
SUPPL38Null7
SUPPL39Null15

TE Codes

001PrescriptionAA

CDER Filings

SPECGX LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 87804
            [companyName] => SPECGX LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"BUTALBITAL, ACETAMINOPHEN AND CAFFEINE","activeIngredients":"ACETAMINOPHEN; BUTALBITAL; CAFFEINE","strength":"325MG;50MG;40MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"BUTALBITAL, ACETAMINOPHEN AND CAFFEINE","submission":"ACETAMINOPHEN; BUTALBITAL; CAFFEINE","actionType":"325MG;50MG;40MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.